These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 658053)

  • 1. Biosynthesis of thromboxane B2 and 12-L-hydroxy-5,8,10-heptadecatrienoic acid in human platelets. Evidence for a common enzymatic pathway.
    Raz A; Aharony D; Kenig-Wakshal R
    Eur J Biochem; 1978 May; 86(2):447-54. PubMed ID: 658053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of an inhibitor of TXA2 synthesis and of PGE2 on the formation of 12-L-hydroxy-5,8,10-heptadecatrienoic acid in human platelets.
    Vincent JE; Zijlstra FJ; van Vliet H
    Adv Prostaglandin Thromboxane Res; 1980; 6():463-6. PubMed ID: 7386279
    [No Abstract]   [Full Text] [Related]  

  • 3. Selective inhibition of prostaglandin endoperoxide thromboxane isomerase by 1-carboxyalkylimidazoles.
    Yoshimoto T; Yamamoto S; Hayaishi O
    Prostaglandins; 1978 Oct; 16(4):529-40. PubMed ID: 725083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Purification of thromboxane synthetase and evidence of two distinct mechanisms for the formation of 12-L-hydroxy-5,8,10-heptadecatrienoic acid by porcine lung microsomes.
    Hall ER; Tai HH
    Biochim Biophys Acta; 1981 Sep; 665(3):498-503. PubMed ID: 7197552
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Solubilization and resolution of thromboxane synthesizing system from microsomes of bovine blood platelets.
    Yoshimoto T; Yamamoto S; Okuma M; Hayaishi O
    J Biol Chem; 1977 Aug; 252(16):5871-4. PubMed ID: 885887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thromboxane A2 is the major arachidonic acid metabolite of human cortical hydronephrotic tissue.
    Morrison AR; Thornton F; Blumberg A; Vaughan ED
    Prostaglandins; 1981 Mar; 21(3):471-81. PubMed ID: 6894498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of the formation of thromboxane B2 (TxB2), 12L-hydroxy-5,8,10 heptadecatrienoic acid (HHT) and 12L-hydroxy-5,8,10,14 eicosatrienoic acid (HETE) from arachidonic acid and of the TxB2 :HHT, TxB2 :HETE and (TxB2 +HHT) :HETE ratio in human platelets. Possible use in diagnostic purposes.
    Vincent JE; Zijlstra FJ; van Vliet H
    Prostaglandins Med; 1980 Aug; 5(2):79-84. PubMed ID: 7413847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies on the thromboxane synthesizing system in human platelet microsomes.
    Tai HH; Yuan B
    Biochim Biophys Acta; 1978 Dec; 531(3):286-94. PubMed ID: 737191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostaglandin biosynthesis in platelets: demonstration and role of prostaglandin H2 leads to E2 isomerase.
    Raz A; Aharony D
    Res Commun Chem Pathol Pharmacol; 1978 Sep; 21(3):507-15. PubMed ID: 705027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kinetic studies on the conversion of prostaglandin endoperoxide PGH2 by thromboxane synthase.
    Anderson MW; Crutchley DJ; Tainer BE; Eling TE
    Prostaglandins; 1978 Oct; 16(4):563-70. PubMed ID: 725086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. From studies of biochemical mechanism to novel biological mediators: prostaglandin endoperoxides, thromboxanes, and leukotrienes. Nobel Lecture, 8 December 1982.
    Samuelsson B
    Biosci Rep; 1983 Sep; 3(9):791-813. PubMed ID: 6315101
    [No Abstract]   [Full Text] [Related]  

  • 12. Metabolism of 7,10,13,16-docosatetraenoic acid to dihomo-thromboxane, 14-hydroxy-7,10,12-nonadecatrienoic acid and hydroxy fatty acids by human platelets.
    VanRollins M; Horrocks L; Sprecher H
    Biochim Biophys Acta; 1985 Feb; 833(2):272-80. PubMed ID: 3918572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased thromboxane B2 biosynthesis in platelets.
    Kawaguchi H; Ishibashi T; Imai Y
    Lipids; 1982 Sep; 17(9):577-84. PubMed ID: 6815401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vinca alkaloids inhibit conversion of arachidonic acid to thromboxane by human platelet microsomes: comparison with other microtubule-active drugs.
    Maguire MH; Csonka-Khalifah L
    Biochim Biophys Acta; 1987 Oct; 921(3):426-36. PubMed ID: 3117116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An antithrombotic agent, NQ301, inhibits thromboxane A2 receptor and synthase activity in rabbit platelets.
    Jin YR; Cho MR; Lee KS; Lee JJ; Lim Y; Han XH; Oh KW; Hong JT; Yoo HS; Yun YP
    Basic Clin Pharmacol Toxicol; 2005 Sep; 97(3):162-7. PubMed ID: 16128910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enzymatic synthesis of 15-hydroperoxythromboxane A2 and 12-hydroperoxy-5,8,10-heptadecatrienoic acid.
    Hammarström S
    J Biol Chem; 1980 Jan; 255(2):518-21. PubMed ID: 7356630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of platelet aggregation by 1-alkylimidazole derivatives, thromboxane A synthetase inhibitors.
    Kayama N; Sakaguchi K; Kaneko S; Kubota T; Fukuzawa T; Kawamura S; Yoshimoto T; Yamamoto S
    Prostaglandins; 1981 Apr; 21(4):543-54. PubMed ID: 7196056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparative study of the involvement of the prostaglandin H2/thromboxane A2 pathway in intravascular platelet aggregation in guinea-pigs and rats.
    Mallarkey G; Smith GM
    Br J Pharmacol; 1985 Feb; 84(2):425-30. PubMed ID: 3156648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis of thromboxane A2 by non-aggregating dog platelets challenged with arachidonic acid or with prostaglandin H2.
    Chignard M; Vargaftig BB
    Prostaglandins; 1977 Aug; 14(2):222-40. PubMed ID: 197571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Separation of prostaglandins, thromboxane, hydroxy fatty acids and arachidonic acid by high pressure liquid chromatography.
    Eling T; Warnock R; Dick D; Tainer B
    Prostaglandins Med; 1980 Nov; 5(5):345-55. PubMed ID: 6779300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.